These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37942587)

  • 1. Illuminating the structural basis of human neurokinin 1 receptor (NK1R) antagonism through classical all-atoms molecular dynamics simulations.
    Mishra S; Rout M; Singh MK; Dehury B; Pati S
    J Cell Biochem; 2023 Nov; 124(11):1848-1869. PubMed ID: 37942587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists.
    Schöppe J; Ehrenmann J; Klenk C; Rucktooa P; Schütz M; Doré AS; Plückthun A
    Nat Commun; 2019 Jan; 10(1):17. PubMed ID: 30604743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
    Nizam E; Erin N
    Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.
    Fulenwider HD; Smith BM; Nichenko AS; Carpenter JM; Nennig SE; Cheng K; Rice KC; Schank JR
    J Neuroinflammation; 2018 Feb; 15(1):60. PubMed ID: 29486768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurokinin 1 Receptor Antagonists for Pruritus.
    Alam M; Buddenkotte J; Ahmad F; Steinhoff M
    Drugs; 2021 Apr; 81(6):621-634. PubMed ID: 33675531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.
    Jensen DD; Lieu T; Halls ML; Veldhuis NA; Imlach WL; Mai QN; Poole DP; Quach T; Aurelio L; Conner J; Herenbrink CK; Barlow N; Simpson JS; Scanlon MJ; Graham B; McCluskey A; Robinson PJ; Escriou V; Nassini R; Materazzi S; Geppetti P; Hicks GA; Christie MJ; Porter CJH; Canals M; Bunnett NW
    Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
    Lelas S; Li YW; Wallace-Boone TL; Taber MT; Newton AE; Pieschl RL; Davis CD; Molski TF; Newberry KS; Parker MF; Gillman KW; Bronson JJ; Macor JE; Lodge NJ
    Neuropharmacology; 2013 Oct; 73():232-40. PubMed ID: 23770339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin-1 receptor is highly expressed in cervical cancer and its antagonist induces cervical cancer cell apoptosis.
    Guan L; Yuan S; Ma J; Liu H; Huang L; Zhang F
    Eur J Histochem; 2023 Jan; 67(1):. PubMed ID: 36629320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking.
    Schank JR; Nelson BS; Damadzic R; Tapocik JD; Yao M; King CE; Rowe KE; Cheng K; Rice KC; Heilig M
    Neuropharmacology; 2015 Dec; 99():106-14. PubMed ID: 26188146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NK1R attenuates LPS-induced microglial inflammation and consequent death of PC12 cells.
    Jiang W; Wang X; Wang W; Hua F; Zhang Z; Zhang Z; Xiang J; Yang X
    Brain Res Bull; 2020 Sep; 162():115-124. PubMed ID: 32540418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.
    Akazawa T; Kwatra SG; Goldsmith LE; Richardson MD; Cox EA; Sampson JH; Kwatra MM
    J Neurochem; 2009 May; 109(4):1079-86. PubMed ID: 19519779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK1R/5-HT1AR interaction is related to the regulation of melanogenesis.
    Wu H; Zhao Y; Huang Q; Cai M; Pan Q; Fu M; An X; Xia Z; Liu M; Jin Y; He L; Shang J
    FASEB J; 2018 Jun; 32(6):3193-3214. PubMed ID: 29430989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
    Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
    Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR.
    Zhang XW; Li L; Hu WQ; Hu MN; Tao Y; Hu H; Miao XK; Yang WL; Zhu Q; Mou LY
    Cell Death Dis; 2022 Jan; 13(1):41. PubMed ID: 35013118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes.
    Mai QN; Shenoy P; Quach T; Retamal JS; Gondin AB; Yeatman HR; Aurelio L; Conner JW; Poole DP; Canals M; Nowell CJ; Graham B; Davis TP; Briddon SJ; Hill SJ; Porter CJH; Bunnett NW; Halls ML; Veldhuis NA
    J Biol Chem; 2021; 296():100345. PubMed ID: 33515548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
    Nizam E; Köksoy S; Erin N
    Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
    Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
    Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.
    Guillemyn K; Kleczkowska P; Lesniak A; Dyniewicz J; Van der Poorten O; Van den Eynde I; Keresztes A; Varga E; Lai J; Porreca F; Chung NN; Lemieux C; Mika J; Rojewska E; Makuch W; Van Duppen J; Przewlocka B; Vanden Broeck J; Lipkowski AW; Schiller PW; Tourwé D; Ballet S
    Eur J Med Chem; 2015 Mar; 92():64-77. PubMed ID: 25544687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P and the Neurokinin-1 Receptor: The New CRF.
    Schank JR; Heilig M
    Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.